Publications by authors named "Laura Vita Q Paglicawan"
West J Emerg Med
November 2024
Article Synopsis
- The study focuses on assessing the impact of buprenorphine-naloxone on mortality and remission rates among patients with opioid use disorder (OUD), amidst rising opioid-related deaths in the U.S.
- Using data from nearly 92 million medical records, the research compares outcomes between patients treated with buprenorphine-naloxone and a control group not receiving this treatment.
- Findings indicate that patients on buprenorphine-naloxone experienced 34% fewer deaths and approximately 1.9 times higher remission rates compared to those who did not receive the medication.
